These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2611766)

  • 1. Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum.
    Carvey PM; Ptak LR; Kao L; Klawans HL
    Clin Neuropharmacol; 1989 Oct; 12(5):425-34. PubMed ID: 2611766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures.
    Carvey PM; Ptak LR; Lo ES; Lin DH; Buhrfiend CM; Goetz CG; Klawans HL
    Exp Neurol; 1991 Oct; 114(1):28-34. PubMed ID: 1915732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of chronic haloperidol and sulpiride treatment on nigral and striatal GABA content.
    Nicoletti F; Patti F; Condorelli DF; Rampello L; Giammona G; Di Giorgio RM; Canonico PL; Scapagnini U
    J Neurochem; 1981 Oct; 37(4):1048-51. PubMed ID: 7320718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
    Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
    Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity.
    Carvey PM; Kao LC; Zhang TJ; Amdur RL; Lin DH; Singh R; Klawans HL
    Pharmacol Biochem Behav; 1990 Feb; 35(2):291-300. PubMed ID: 2320636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
    Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
    Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol.
    Yamada S; Yokoo H; Harajiri S; Nishi S
    Eur J Pharmacol; 1991 Jan; 192(1):141-5. PubMed ID: 2040357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release.
    Osborne PG; O'Connor WT; Beck O; Ungerstedt U
    Brain Res; 1994 Jan; 634(1):20-30. PubMed ID: 7908848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of apomorphine-induced circling behaviour after striatal dopamine receptor denervation.
    Oberlander C; Dumont C; Boissier JR
    Eur J Pharmacol; 1980 Mar; 62(1):107-10. PubMed ID: 7189465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1993 Feb; 232(1):1-6. PubMed ID: 8458389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of striatal dopaminergic grafts by haloperidol.
    Herman JP; Choulli K; Le Moal M
    Brain Res Bull; 1985 Dec; 15(6):543-6. PubMed ID: 3936594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal synaptophysin levels are not indicative of dopaminergic supersensitivity.
    Marin C; Tolosa E
    Neuropharmacology; 1997 Aug; 36(8):1115-7. PubMed ID: 9294977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat.
    Lai H; Kazi MS; Carino MA; Horita A
    Life Sci; 1982 Mar; 30(10):821-6. PubMed ID: 7200179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats.
    Grimm JW; See RE
    Neuroscience; 2000; 100(3):507-14. PubMed ID: 11098113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.